Commentary|Slideshows|March 10, 2025

February's Special Report: Child and Adolescent Psychiatry

Author(s)Peter S. Jensen, MD, Kenneth J. Bender, PharmD, MA, James M. Greenblatt, MD

Discover key insights from February’s Special Report on child and adolescent psychiatry, exploring overlooked diagnoses, new research, and the complex impact of social media on youth mental health.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe

Related Content

Psyched Perspectives: ADHD in Underrecognized Populations, With Paige Walton, MD

ByFrank A. Clark, MD,Paige Walton, MD

August 19th 2026

HLP003, Deuterated Psilocin, as an Adjunctive Therapy for Major Depressive Disorder

ByKen Kramer, PhD

August 17th 2026

Home-Based tDCS for Depression: Expanding Access to Neuromodulation Treatment

ByGrethel Perez Meek, DO,Yazan Al-Khalila, MD,Clara Bing-Bauer, MD,Albert Dickan, MD,Haley Schuster, MD,Mark Mullen, MD,Rajesh R. Tampi, MD, MS, DFAPA, DFAAGP

August 17th 2026

Podcast: Exploring Entactogens With Hiroe Imai Hu, DO, and James W. Murrough, MD, PhD

ByJenessa Johnston, PhD,Hiroe Hu, DO,James Murrough, MD, PhD

August 13th 2026

Entactogens as a New Frontier for Mood and Anxiety Disorders: A Conversation With Hiroe Imai Hu, DO, and James W. Murrough, MD, PhD

ByJenessa Johnston, PhD

August 13th 2026

Latest CME

Video

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

Video

Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia

Ilan Melnick, MD; Linda Collado, MD, DABPN, FAPA; Maria Collado, MD, FAPA

Video

Expert Illustrations & Commentary: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Juan D. Oms, MD, FAPA; Linda Collado, MD, DABPN, FAPA; Ginger Shupe, MD

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

February's Special Report: Child and Adolescent Psychiatry

Related Content

Psyched Perspectives: ADHD in Underrecognized Populations, With Paige Walton, MD

HLP003, Deuterated Psilocin, as an Adjunctive Therapy for Major Depressive Disorder

Home-Based tDCS for Depression: Expanding Access to Neuromodulation Treatment

Podcast: Exploring Entactogens With Hiroe Imai Hu, DO, and James W. Murrough, MD, PhD

Entactogens as a New Frontier for Mood and Anxiety Disorders: A Conversation With Hiroe Imai Hu, DO, and James W. Murrough, MD, PhD

Latest CME

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia

Expert Illustrations & Commentary: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Trending on Psychiatric Times

Neuropsychiatry in the News: Wearable Technology for Parkinson Disease, Ecopipam for Tourette Syndrome

Update on Varenicline for Smoking Cessation in Patients With Bipolar Disorder

HLP003, Deuterated Psilocin, as an Adjunctive Therapy for Major Depressive Disorder

Psyched Perspectives: ADHD in Underrecognized Populations, With Paige Walton, MD

Home-Based tDCS for Depression: Expanding Access to Neuromodulation Treatment